Bris­tol My­ers joins As­traZeneca in agree­ing to drug price ne­go­ti­a­tion terms ahead of first dead­line

Phar­ma com­pa­nies are now re­luc­tant­ly agree­ing to par­tic­i­pate in the Cen­ter for Medicare and Med­ic­aid Ser­vices’ first round of ne­go­ti­a­tions for 10 drugs.

Ahead of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER